Paper33014530
Roles of Biomarkers in Myocardial Fibrosis.
Ding Y and 7 others. Aging Dis, 2020. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Roles of Biomarkers in Myocardial Fibrosis. Papers, record 33014530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33014530
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30443020 | Loss of miR-144 signaling interrupts extracellular matrix remodeling after myocardial infarction leading to worsened cardiac function. | Sci Rep | 2018 | https://conductscience.org/library/papers/30443020 | PubMed |
| 2 | 28373589 | Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63-Integrin β1 Interaction. | Hypertension | 2017 | https://conductscience.org/library/papers/28373589 | PubMed |
| 3 | 21283061 | Activation of hypoxia-inducible factor 1 in skeletal muscle cells after exposure to damaged muscle cell debris. | Shock | 2011 | https://conductscience.org/library/papers/21283061 | PubMed |
| 4 | 20061521 | Plasma soluble corin in patients with heart failure. | Circ Heart Fail | 2010 | https://conductscience.org/library/papers/20061521 | PubMed |
| 5 | 20493567 | The prognostic value of circulating markers of collagen turnover after acute myocardial infarction. | Int J Cardiol | 2011 | https://conductscience.org/library/papers/20493567 | PubMed |
| 6 | 21498085 | Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. | Cytokine | 2011 | https://conductscience.org/library/papers/21498085 | PubMed |
| 7 | 15956033 | Connective tissue growth factor and cardiac fibrosis after myocardial infarction. | J Histochem Cytochem | 2005 | https://conductscience.org/library/papers/15956033 | PubMed |
| 8 | 31739105 | Astragaloside IV inhibits cardiac fibrosis via miR-135a-TRPM7-TGF-β/Smads pathway. | J Ethnopharmacol | 2020 | https://conductscience.org/library/papers/31739105 | PubMed |
| 9 | 29203887 | Age-dependent increase of oxidative stress regulates microRNA-29 family preserving cardiac health. | Sci Rep | 2017 | https://conductscience.org/library/papers/29203887 | PubMed |
| 10 | 10880574 | Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10880574 | PubMed |
| 11 | 11741898 | Cloning and characterization of ADAMTS-14, a novel ADAMTS displaying high homology with ADAMTS-2 and ADAMTS-3. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11741898 | PubMed |
| 12 | 3456350 | Molecular assembly, secretion, and matrix deposition of type VI collagen. | J Cell Biol | 1986 | https://conductscience.org/library/papers/3456350 | PubMed |
| 13 | 3038863 | The collagen substrate specificity of human neutrophil collagenase. | J Biol Chem | 1987 | https://conductscience.org/library/papers/3038863 | PubMed |
| 14 | 30129221 | Silencing CTGF/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/30129221 | PubMed |
| 15 | 30983140 | The role and mechanism of transforming growth factor beta 3 in human myocardial infarction-induced myocardial fibrosis. | J Cell Mol Med | 2019 | https://conductscience.org/library/papers/30983140 | PubMed |
| 16 | 12154103 | TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension. | Hypertension | 2002 | https://conductscience.org/library/papers/12154103 | PubMed |
| 17 | 17109837 | The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. | Cardiovasc Res | 2007 | https://conductscience.org/library/papers/17109837 | PubMed |
| 18 | 24391209 | Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation. | J Immunol | 2014 | https://conductscience.org/library/papers/24391209 | PubMed |
| 19 | 30784673 | Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/30784673 | PubMed |
| 20 | 27924061 | The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study. | Oncotarget | 2017 | https://conductscience.org/library/papers/27924061 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42765499 | Sphingomyelin as a key negative mediator in atrial fibrillation via lipid profiling analysis and functional identification. | Europace | 2026 | https://conductscience.org/library/papers/42765499 | PubMed |
| 42461709 | Human pericardial macrophages suppress cardiac fibrosis through cystatin C signaling after myocardial infarction. | JCI Insight | 2026 | https://conductscience.org/library/papers/42461709 | PubMed |
| 42422155 | ACE inhibitors reduce the risk of myocardial fibrosis post-cardiac injury: a systematic review. | Br J Cardiol | 2025 | https://conductscience.org/library/papers/42422155 | PubMed |
| 42299347 | Myocardial fibrosis and viability: the role of imaging and biomarkers in patients with chronic total occlusion on coronary angiography. | Biochem Med (Zagreb) | 2026 | https://conductscience.org/library/papers/42299347 | PubMed |
| 42288762 | Epicardial fat is associated with prevalent heart failure and adverse cardiac remodeling in atrial fibrillation. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/42288762 | PubMed |
| 42194704 | Myocardial Fibrosis in Cardiovascular Disease: An Integrative Biomarker-Imaging Framework Linking Molecular Mechanisms to Structural Phenotypes. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194704 | PubMed |
| 42042031 | Dynamic Organelle Remodeling in HIV-Associated Myocardial Disease: Mechanisms, Fibrotic Pathways, and Therapeutic Opportunities. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42042031 | PubMed |
| 41885708 | Ginsenoside Rb1 Mitigates Myocardial Fibrosis Through Inhibiting Exosomal-Derived miRNA-21-Associated Inflammation and Cardiac Signaling. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/41885708 | PubMed |
| 41751834 | Myocardial Matrix Metalloproteinase 3 Protein Expression in Ischemic Heart Failure. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751834 | PubMed |
| 41079577 | Regulatory mechanisms of exercise-induced physiological cardiac hypertrophy: progress and prospects. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/41079577 | PubMed |
| 40908522 | Therapeutic Targets for Myocardial Fibrosis: A Comprehensive Review of Current and Emerging Approaches. | Cardiovasc Hematol Disord Drug Targets | 2026 | https://conductscience.org/library/papers/40908522 | PubMed |
| 40791777 | Nanomedicine for Diagnosis and Treatment of Cardiac Fibrosis. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40791777 | PubMed |
| 40709209 | Interactions between atrial fibrosis and inflammation in atrial fibrillation. | Front Cardiovasc Med | 2025 | https://conductscience.org/library/papers/40709209 | PubMed |
| 40584624 | Salt sensitivity and myocardial fibrosis: unraveling the silent cardiovascular remodeling. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40584624 | PubMed |
| 40434291 | Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications. | J Physiol | 2026 | https://conductscience.org/library/papers/40434291 | PubMed |
| 40361961 | Utility of Serum Biomarkers of Myocardial Fibrosis in High-Gradient Severe Aortic Stenosis: An Explorative Cardiovascular Magnetic Resonance Imaging-Based Study. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40361961 | PubMed |
| 39619937 | Evaluation of galectin-3 and titin in cats with a sarcomeric gene mutation associated with echocardiography. | Vet World | 2024 | https://conductscience.org/library/papers/39619937 | PubMed |
| 39595654 | Research Progress of Fibroblasts in Human Diseases. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595654 | PubMed |
| 39432214 | Exploring in vivo and in vitro models for heart failure with biomarker insights: a review. | Egypt Heart J | 2024 | https://conductscience.org/library/papers/39432214 | PubMed |
| 39388499 | Preventive and treatment efficiency of dendrosomal nano-curcumin against ISO-induced cardiac fibrosis in mouse model. | PLoS One | 2024 | https://conductscience.org/library/papers/39388499 | PubMed |
Genes56
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33014530
GET https://conductscience.org/api/papers/v1/33014530/references?page=2